市場調査レポート

商品コード

1509672

医薬品用ゼラチンの世界市場の評価：タイプ別、由来別、用途別、機能別、エンドユーザー別、地域別、機会、予測（2017年～2031年）

Pharmaceutical Gelatin Market Assessment, By Type, By Source, By Application, By Function, By End-user, By Region, Opportunities and Forecast, 2017-2031F

出版日: 2024年07月09日
発行: Market Xcel - Markets and Data
ページ情報: 英文 228 Pages
納期: 3～5営業日

カスタマイズ可能

価格

PDF & Excel Printable (Single User License)

USD 4,500 648,270円

レポートPDFを1名の方がご利用頂けるライセンスです。レポートPDFのパスワード保護はありません。PDF内のテキスト等のコピー＆ペーストは可能です。印刷は無制限で可能です。Excelのデータがライセンスに含まれています。

PDF & Excel Printable (Corporate License)

USD 5,700 821,142円

レポートPDFを企業の１カ国の拠点のすべての方がご利用頂けるライセンスです。レポートPDFのパスワード保護はありません。PDF内のテキスト等のコピー＆ペーストは可能ですが、企業内部での利用に限定されます。ご利用に際しては、あらかじめ出版社の許諾を得る必要があります。詳細はお問合せください。印刷は可能です。Excelのデータがライセンスに含まれています。

PDF & Excel Printable (Custom Research License)

USD 8,200 1,181,292円

レポートPDFを企業の１カ国の拠点のすべての方がご利用頂けるライセンスです。レポートPDFのパスワード保護はありません。PDF内のテキスト等のコピー＆ペーストは可能です。印刷は無制限で可能です。Excelのデータがライセンスに含まれています。アナリストアワー100時間が含まれており、レポートのカスタマイズなどにご利用いただけます。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=144.06円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

世界の医薬品用ゼラチンの市場規模は、2023年の12億5,000万米ドルから2031年に19億2,000万米ドルに達すると予測され、2024年～2031年の予測期間にCAGRで5.57%の成長が見込まれます。市場を形成する要因はさまざまです。これには、研究投資の増加、技術の進歩、豚ゼラチンの高い需要、ゼラチンカプセルの人気の向上、欧州市場での需要の増加、拡大機会を求める企業などが含まれます。

市場の重要な促進要因の1つは、研究開発戦略への投資の増加です。これらの戦略は、成長と増産に必要な産業の技術革新と技術の進歩の促進に役立っています。ドラッグデリバリーやゼラチンベースの治療薬の技術の進歩により、ゼラチンは医薬品に新たな用途を見出しています。豚ゼラチンの高い需要も、世界の医薬品用ゼラチン市場の大きな成長促進要因です。豚ゼラチンの優れた品質は、製薬産業での使用に非常に適しています。豚ゼラチンの用途は技術の進歩とともに増加しており、これは将来もこの製品の需要が続くことを示しています。

植物由来のゼラチンカプセルの誕生など、カプセル技術におけるゼラチンカプセルの性能と適応性が進歩によって向上しており、生産者と顧客の両方にとって魅力が増しています。ゼラチンカプセルは、空気、光、微生物の繁殖や汚染から内容物を保護する能力があるため、世界の医薬品用ゼラチン市場で高い需要があります。欧州市場も世界市場の大きな成長促進要因です。欧州連合（EU）の医薬品市場の成長と強力な製薬部門により、医薬品用ゼラチンはますます不可欠になっています。

最後に、企業は多様性と成長を求めています。新しいゼラチンブランドのイントロダクションや既存ブランドの新分野への成長は、このことを明確に示しています。これらの要因は、今後数年間、世界の医薬品用ゼラチン市場のさらなる成長と多様化を促進すると予測されます。

例えば2024年5月、Kerala State Industrial Development Corporation Ltd（KSIDC）とNitta Gelatin Inc. JapanはNitta Gelatin India Ltd（NGIL）を通じて、ケララ州で718万米ドルの拡張プロジェクトを共同で開始しました。このプロジェクトは、ケララ州首相の近年の訪日時に日本の多国籍企業が公表した2,396万米ドルの投資の一部です。

研究活動が市場拡大を後押し

業界の研究開発（R&D）活動の活発化により、世界の医薬品用ゼラチン市場は大規模に拡大しています。製薬企業は、生分解性カプセルや先進のドラッグデリバリーシステムのような最先端のゼラチンベースの製品を開発するため、研究開発に多額の資金を投じています。その結果、GelTYR-Gelatin Tyramineの代替品であるX-Pure-GelDATのような新しいゼラチンのブランドや製品が登場しています。さらに、ゼラチン生産法の開発により、生産性と入手性が向上し、世界の医薬品用ゼラチン市場の拡大が促進されると予測されます。

例えば2022年1月、Darling Ingredients Inc.は、コラーゲンベースのソリューションの世界的リーダーであるRousselot Healthブランドを通じて、カリフォルニアに位置する再生医療研究機関であるTerasaki Institute for Biomedical Innovation（TBI）とパートナーシップを確立しました。RousselotとTIBIは、この戦略的提携を通じて、ゼラチンをベースとした治療法の開発とその臨床応用に共同で取り組みます。RousselotはTIBIにX-Pure GelMAを含むX-Pure改質ゼラチンを提供し、それと引き換えに、研究所や臨床試験を通じてゼラチンがどのように作用するかについての情報を提供します。

技術の進歩が市場の成長に拍車をかける

ナノテクノロジー、3Dプリンティング、AI、機械学習などの技術の進歩が世界の医薬品用ゼラチン市場の成長を促進しています。製薬企業はこれらの技術を活用して、従来のソリューションの機能性や品質を上回る新規のゼラチンベースの商品を生産しています。これらの技術により、ゼラチンをベースとした製品の開発プロセスは、より費用対効果が高く効率的なものとなっています。ゼラチンは、遺伝子治療、ドラッグデリバリーシステム、組織工学などの他の製薬部門でも広く使用されています。これらの技術が世界の医薬品用ゼラチン市場の成長を後押ししているため、製薬産業におけるゼラチンの利用は今後も拡大し続ける見込みです。

当レポートでは、世界の医薬品用ゼラチン市場について調査分析し、市場規模と予測、市場力学、主要企業の情勢と見通しなどを提供しています。

市場規模と予測
- 金額
- 数量
タイプ別
- Aタイプ
- Bタイプ
由来別
- 牛
- 豚
- その他
用途別
- ハードゼラチンカプセル
- ソフトゼラチンカプセル
- その他
機能別
- 安定化
- 増粘
- ゲル化
- その他
エンドユーザー別
- 製薬企業
- バイオテクノロジー企業
- 学術・研究機関
地域別
- 北米
- 欧州
- アジア太平洋
- 南米
- 中東・アフリカ
市場シェア：企業別（2023年）

第5章世界の医薬品用ゼラチン市場の見通し：地域別（2017年～2031年）

北米
- 市場規模と予測
- タイプ別
- 由来別
- 用途別
- 機能別
- エンドユーザー別
- 米国
- カナダ
- メキシコ
欧州
- ドイツ
- フランス
- イタリア
- 英国
- ロシア
- オランダ
- スペイン
- トルコ
- ポーランド
アジア太平洋
- インド
- 中国
- 日本
- オーストラリア
- ベトナム
- 韓国
- インドネシア
- フィリピン
南米
- ブラジル
- アルゼンチン
中東・アフリカ
- サウジアラビア
- アラブ首長国連邦
- 南アフリカ

第6章市場マッピング（2023年）

タイプ別
由来別
用途別
機能別
エンドユーザー別
地域別

第7章マクロ環境と産業構造

需給分析
輸入輸出分析
バリューチェーン分析
PESTEL分析
ポーターのファイブフォース分析

第8章市場力学

成長促進要因
成長抑制要因（課題、抑制要因）

第9章規制枠組みとイノベーション

特許情勢
規制当局の承認
イノベーション/新技術

第10章主要企業の情勢

マーケットリーダー上位5社の競合マトリクス
マーケットリーダー上位5社の市場収益の分析（2023年）
合併と買収/合弁事業（該当する場合）
SWOT分析（市場企業5社）
特許分析（該当する場合）

第11章価格分析

第12章ケーススタディ

第13章主要企業の見通し

Gelita AG
Darling Ingredients Inc.
Nitta Gelatin, Inc.
Tessenderlo Group
Weishardt International
Lonza Group AG
Aspire Pharmaceuticals, Inc.
Junca Gelatines S.L
Gelco International
Trobas Gelatine BV

第14章戦略的推奨

第15章当社について、免責事項

図表

List of Tables

Table 1. Pricing Analysis of Products from Key Players
Table 2. Competition Matrix of Top 5 Market Leaders
Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

Figure 1. Global Pharmaceutical Gelatin Market, By Value, In USD Billion, 2017-2031F
Figure 2. Global Pharmaceutical Gelatin Market, By Volume, In Billion Units, 2017-2031F
Figure 3. Global Pharmaceutical Gelatin Market Share (%), By Type, 2017-2031F
Figure 4. Global Pharmaceutical Gelatin Market Share (%), By Source, 2017-2031F
Figure 5. Global Pharmaceutical Gelatin Market Share (%), By Application, 2017-2031F
Figure 6. Global Pharmaceutical Gelatin Market Share (%), By Function, 2017-2031F
Figure 7. Global Pharmaceutical Gelatin Market Share (%), By End-User, 2017-2031F
Figure 8. Global Pharmaceutical Gelatin Market Share (%), By Region, 2017-2031F
Figure 9. North America Pharmaceutical Gelatin Market, By Value, In USD Billion, 2017-2031F
Figure 10. North America Pharmaceutical Gelatin Market, By Volume, In Billion Units, 2017-2031F
Figure 11. North America Pharmaceutical Gelatin Market Share (%), By Type, 2017-2031F
Figure 12. North America Pharmaceutical Gelatin Market Share (%), By Source, 2017-2031F
Figure 13. North America Pharmaceutical Gelatin Market Share (%), By Application, 2017-2031F
Figure 14. North America Pharmaceutical Gelatin Market Share (%), By Function, 2017-2031F
Figure 15. North America Pharmaceutical Gelatin Market Share (%), By End-User, 2017-2031F
Figure 16. North America Pharmaceutical Gelatin Market Share (%), By Country, 2017-2031F
Figure 17. United States Pharmaceutical Gelatin Market, By Value, In USD Billion, 2017-2031F
Figure 18. United States Pharmaceutical Gelatin Market, By Volume, In Billion Units, 2017-2031F
Figure 19. United States Pharmaceutical Gelatin Market Share (%), By Type, 2017-2031F
Figure 20. United States Pharmaceutical Gelatin Market Share (%), By Source, 2017-2031F
Figure 21. United States Pharmaceutical Gelatin Market Share (%), By Application, 2017-2031F
Figure 22. United States Pharmaceutical Gelatin Market Share (%), By Function, 2017-2031F
Figure 23. United States Pharmaceutical Gelatin Market Share (%), By End-User, 2017-2031F
Figure 24. Canada Pharmaceutical Gelatin Market, By Value, In USD Billion, 2017-2031F
Figure 25. Canada Pharmaceutical Gelatin Market, By Volume, In Billion Units, 2017-2031F
Figure 26. Canada Pharmaceutical Gelatin Market Share (%), By Type, 2017-2031F
Figure 27. Canada Pharmaceutical Gelatin Market Share (%), By Source, 2017-2031F
Figure 28. Canada Pharmaceutical Gelatin Market Share (%), By Application, 2017-2031F
Figure 29. Canada Pharmaceutical Gelatin Market Share (%), By Function, 2017-2031F
Figure 30. Canada Pharmaceutical Gelatin Market Share (%), By End-User, 2017-2031F
Figure 31. Mexico Pharmaceutical Gelatin Market, By Value, In USD Billion, 2017-2031F
Figure 32. Mexico Pharmaceutical Gelatin Market, By Volume, In Billion Units, 2017-2031F
Figure 33. Mexico Pharmaceutical Gelatin Market Share (%), By Type, 2017-2031F
Figure 34. Mexico Pharmaceutical Gelatin Market Share (%), By Source, 2017-2031F
Figure 35. Mexico Pharmaceutical Gelatin Market Share (%), By Application, 2017-2031F
Figure 36. Mexico Pharmaceutical Gelatin Market Share (%), By Function, 2017-2031F
Figure 37. Mexico Pharmaceutical Gelatin Market Share (%), By End-User, 2017-2031F
Figure 38. Europe Pharmaceutical Gelatin Market, By Value, In USD Billion, 2017-2031F
Figure 39. Europe Pharmaceutical Gelatin Market, By Volume, In Billion Units, 2017-2031F
Figure 40. Europe Pharmaceutical Gelatin Market Share (%), By Type, 2017-2031F
Figure 41. Europe Pharmaceutical Gelatin Market Share (%), By Source, 2017-2031F
Figure 42. Europe Pharmaceutical Gelatin Market Share (%), By Application, 2017-2031F
Figure 43. Europe Pharmaceutical Gelatin Market Share (%), By Function, 2017-2031F
Figure 44. Europe Pharmaceutical Gelatin Market Share (%), By End-User, 2017-2031F
Figure 45. Europe Pharmaceutical Gelatin Market Share (%), By Country, 2017-2031F
Figure 46. Germany Pharmaceutical Gelatin Market, By Value, In USD Billion, 2017-2031F
Figure 47. Germany Pharmaceutical Gelatin Market, By Volume, In Billion Units, 2017-2031F
Figure 48. Germany Pharmaceutical Gelatin Market Share (%), By Type, 2017-2031F
Figure 49. Germany Pharmaceutical Gelatin Market Share (%), By Source, 2017-2031F
Figure 50. Germany Pharmaceutical Gelatin Market Share (%), By Application, 2017-2031F
Figure 51. Germany Pharmaceutical Gelatin Market Share (%), By Function, 2017-2031F
Figure 52. Germany Pharmaceutical Gelatin Market Share (%), By End-User, 2017-2031F
Figure 53. France Pharmaceutical Gelatin Market, By Value, In USD Billion, 2017-2031F
Figure 54. France Pharmaceutical Gelatin Market, By Volume, In Billion Units, 2017-2031F
Figure 55. France Pharmaceutical Gelatin Market Share (%), By Type, 2017-2031F
Figure 56. France Pharmaceutical Gelatin Market Share (%), By Source, 2017-2031F
Figure 57. France Pharmaceutical Gelatin Market Share (%), By Application, 2017-2031F
Figure 58. France Pharmaceutical Gelatin Market Share (%), By Function, 2017-2031F
Figure 59. France Pharmaceutical Gelatin Market Share (%), By End-User, 2017-2031F
Figure 60. Italy Pharmaceutical Gelatin Market, By Value, In USD Billion, 2017-2031F
Figure 61. Italy Pharmaceutical Gelatin Market, By Volume, In Billion Units, 2017-2031F
Figure 62. Italy Pharmaceutical Gelatin Market Share (%), By Type, 2017-2031F
Figure 63. Italy Pharmaceutical Gelatin Market Share (%), By Source, 2017-2031F
Figure 64. Italy Pharmaceutical Gelatin Market Share (%), By Application, 2017-2031F
Figure 65. Italy Pharmaceutical Gelatin Market Share (%), By Function, 2017-2031F
Figure 66. Italy Pharmaceutical Gelatin Market Share (%), By End-User, 2017-2031F
Figure 67. United Kingdom Pharmaceutical Gelatin Market, By Value, In USD Billion, 2017-2031F
Figure 68. United Kingdom Pharmaceutical Gelatin Market, By Volume, In Billion Units, 2017-2031F
Figure 69. United Kingdom Pharmaceutical Gelatin Market Share (%), By Type, 2017-2031F
Figure 70. United Kingdom Pharmaceutical Gelatin Market Share (%), By Source, 2017-2031F
Figure 71. United Kingdom Pharmaceutical Gelatin Market Share (%), By Application, 2017-2031F
Figure 72. United Kingdom Pharmaceutical Gelatin Market Share (%), By Function, 2017-2031F
Figure 73. United Kingdom Pharmaceutical Gelatin Market Share (%), By End-User, 2017-2031F
Figure 74. Russia Pharmaceutical Gelatin Market, By Value, In USD Billion, 2017-2031F
Figure 75. Russia Pharmaceutical Gelatin Market, By Volume, In Billion Units, 2017-2031F
Figure 76. Russia Pharmaceutical Gelatin Market Share (%), By Type, 2017-2031F
Figure 77. Russia Pharmaceutical Gelatin Market Share (%), By Source, 2017-2031F
Figure 78. Russia Pharmaceutical Gelatin Market Share (%), By Application, 2017-2031F
Figure 79. Russia Pharmaceutical Gelatin Market Share (%), By Function, 2017-2031F
Figure 80. Russia Pharmaceutical Gelatin Market Share (%), By End-User, 2017-2031F
Figure 81. Netherlands Pharmaceutical Gelatin Market, By Value, In USD Billion, 2017-2031F
Figure 82. Netherlands Pharmaceutical Gelatin Market, By Volume, In Billion Units, 2017-2031F
Figure 83. Netherlands Pharmaceutical Gelatin Market Share (%), By Type, 2017-2031F
Figure 84. Netherlands Pharmaceutical Gelatin Market Share (%), By Source, 2017-2031F
Figure 85. Netherlands Pharmaceutical Gelatin Market Share (%), By Application, 2017-2031F
Figure 86. Netherlands Pharmaceutical Gelatin Market Share (%), By Function, 2017-2031F
Figure 87. Netherlands Pharmaceutical Gelatin Market Share (%), By End-User, 2017-2031F
Figure 88. Spain Pharmaceutical Gelatin Market, By Value, In USD Billion, 2017-2031F
Figure 89. Spain Pharmaceutical Gelatin Market, By Volume, In Billion Units, 2017-2031F
Figure 90. Spain Pharmaceutical Gelatin Market Share (%), By Type, 2017-2031F
Figure 91. Spain Pharmaceutical Gelatin Market Share (%), By Source, 2017-2031F
Figure 92. Spain Pharmaceutical Gelatin Market Share (%), By Application, 2017-2031F
Figure 93. Spain Pharmaceutical Gelatin Market Share (%), By Function, 2017-2031F
Figure 94. Spain Pharmaceutical Gelatin Market Share (%), By End-User, 2017-2031F
Figure 95. Turkey Pharmaceutical Gelatin Market, By Value, In USD Billion, 2017-2031F
Figure 96. Turkey Pharmaceutical Gelatin Market, By Volume, In Billion Units, 2017-2031F
Figure 97. Turkey Pharmaceutical Gelatin Market Share (%), By Type, 2017-2031F
Figure 98. Turkey Pharmaceutical Gelatin Market Share (%), By Source, 2017-2031F
Figure 99. Turkey Pharmaceutical Gelatin Market Share (%), By Application, 2017-2031F
Figure 100. Turkey Pharmaceutical Gelatin Market Share (%), By Function, 2017-2031F
Figure 101. Turkey Pharmaceutical Gelatin Market Share (%), By End-User, 2017-2031F
Figure 102. Poland Pharmaceutical Gelatin Market, By Value, In USD Billion, 2017-2031F
Figure 103. Poland Pharmaceutical Gelatin Market, By Volume, In Billion Units, 2017-2031F
Figure 104. Poland Pharmaceutical Gelatin Market Share (%), By Type, 2017-2031F
Figure 105. Poland Pharmaceutical Gelatin Market Share (%), By Source, 2017-2031F
Figure 106. Poland Pharmaceutical Gelatin Market Share (%), By Application, 2017-2031F
Figure 107. Poland Pharmaceutical Gelatin Market Share (%), By Function, 2017-2031F
Figure 108. Poland Pharmaceutical Gelatin Market Share (%), By End-User, 2017-2031F
Figure 109. South America Pharmaceutical Gelatin Market, By Value, In USD Billion, 2017-2031F
Figure 110. South America Pharmaceutical Gelatin Market, By Volume, In Billion Units, 2017-2031F
Figure 111. South America Pharmaceutical Gelatin Market Share (%), By Type, 2017-2031F
Figure 112. South America Pharmaceutical Gelatin Market Share (%), By Source, 2017-2031F
Figure 113. South America Pharmaceutical Gelatin Market Share (%), By Application, 2017-2031F
Figure 114. South America Pharmaceutical Gelatin Market Share (%), By Function, 2017-2031F
Figure 115. South America Pharmaceutical Gelatin Market Share (%), By End-User, 2017-2031F
Figure 116. South America Pharmaceutical Gelatin Market Share (%), By Country, 2017-2031F
Figure 117. Brazil Pharmaceutical Gelatin Market, By Value, In USD Billion, 2017-2031F
Figure 118. Brazil Pharmaceutical Gelatin Market, By Volume, In Billion Units, 2017-2031F
Figure 119. Brazil Pharmaceutical Gelatin Market Share (%), By Type, 2017-2031F
Figure 120. Brazil Pharmaceutical Gelatin Market Share (%), By Source, 2017-2031F
Figure 121. Brazil Pharmaceutical Gelatin Market Share (%), By Application, 2017-2031F
Figure 122. Brazil Pharmaceutical Gelatin Market Share (%), By Function, 2017-2031F
Figure 123. Brazil Pharmaceutical Gelatin Market Share (%), By End-User, 2017-2031F
Figure 124. Argentina Pharmaceutical Gelatin Market, By Value, In USD Billion, 2017-2031F
Figure 125. Argentina Pharmaceutical Gelatin Market, By Volume, In Billion Units, 2017-2031F
Figure 126. Argentina Pharmaceutical Gelatin Market Share (%), By Type, 2017-2031F
Figure 127. Argentina Pharmaceutical Gelatin Market Share (%), By Source, 2017-2031F
Figure 128. Argentina Pharmaceutical Gelatin Market Share (%), By Application, 2017-2031F
Figure 129. Argentina Pharmaceutical Gelatin Market Share (%), By Function, 2017-2031F
Figure 130. Argentina Pharmaceutical Gelatin Market Share (%), By End-User, 2017-2031F
Figure 131. Asia-Pacific Pharmaceutical Gelatin Market, By Value, In USD Billion, 2017-2031F
Figure 132. Asia-Pacific Pharmaceutical Gelatin Market, By Volume, In Billion Units, 2017-2031F
Figure 133. Asia-Pacific Pharmaceutical Gelatin Market Share (%), By Type, 2017-2031F
Figure 134. Asia-Pacific Pharmaceutical Gelatin Market Share (%), By Source, 2017-2031F
Figure 135. Asia-Pacific Pharmaceutical Gelatin Market Share (%), By Application, 2017-2031F
Figure 136. Asia-Pacific Pharmaceutical Gelatin Market Share (%), By Function, 2017-2031F
Figure 137. Asia- Pacific Pharmaceutical Gelatin Market Share (%), By End-User, 2017-2031F
Figure 138. Asia-Pacific Pharmaceutical Gelatin Market Share (%), By Country, 2017-2031F
Figure 139. India Pharmaceutical Gelatin Market, By Value, In USD Billion, 2017-2031F
Figure 140. India Pharmaceutical Gelatin Market, By Volume, In Billion Units, 2017-2031F
Figure 141. India Pharmaceutical Gelatin Market Share (%), By Type, 2017-2031F
Figure 142. India Pharmaceutical Gelatin Market Share (%), By Source, 2017-2031F
Figure 143. India Pharmaceutical Gelatin Market Share (%), By Application, 2017-2031F
Figure 144. India Pharmaceutical Gelatin Market Share (%), By Function, 2017-2031F
Figure 145. India Pharmaceutical Gelatin Market Share (%), By End-User, 2017-2031F
Figure 146. China Pharmaceutical Gelatin Market, By Value, In USD Billion, 2017-2031F
Figure 147. China Pharmaceutical Gelatin Market, By Volume, In Billion Units, 2017-2031F
Figure 148. China Pharmaceutical Gelatin Market Share (%), By Type, 2017-2031F
Figure 149. China Pharmaceutical Gelatin Market Share (%), By Source, 2017-2031F
Figure 150. China Pharmaceutical Gelatin Market Share (%), By Application, 2017-2031F
Figure 151. China Pharmaceutical Gelatin Market Share (%), By Function, 2017-2031F
Figure 152. China Pharmaceutical Gelatin Market Share (%), By End-User, 2017-2031F
Figure 153. Japan Pharmaceutical Gelatin Market, By Value, In USD Billion, 2017-2031F
Figure 154. Japan Pharmaceutical Gelatin Market, By Volume, In Billion Units, 2017-2031F
Figure 155. Japan Pharmaceutical Gelatin Market Share (%), By Type, 2017-2031F
Figure 156. Japan Pharmaceutical Gelatin Market Share (%), By Source, 2017-2031F
Figure 157. Japan Pharmaceutical Gelatin Market Share (%), By Application, 2017-2031F
Figure 158. Japan Pharmaceutical Gelatin Market Share (%), By Function, 2017-2031F
Figure 159. Japan Pharmaceutical Gelatin Market Share (%), By End-User, 2017-2031F
Figure 160. Australia Pharmaceutical Gelatin Market, By Value, In USD Billion, 2017-2031F
Figure 161. Australia Pharmaceutical Gelatin Market, By Volume, In Billion Units, 2017-2031F
Figure 162. Australia Pharmaceutical Gelatin Market Share (%), By Type, 2017-2031F
Figure 163. Australia Pharmaceutical Gelatin Market Share (%), By Source, 2017-2031F
Figure 164. Australia Pharmaceutical Gelatin Market Share (%), By Application, 2017-2031F
Figure 165. Australia Pharmaceutical Gelatin Market Share (%), By Function, 2017-2031F
Figure 166. Australia Pharmaceutical Gelatin Market Share (%), By End-User, 2017-2031F
Figure 167. Vietnam Pharmaceutical Gelatin Market, By Value, In USD Billion, 2017-2031F
Figure 168. Vietnam Pharmaceutical Gelatin Market, By Volume, In Billion Units, 2017-2031F
Figure 169. Vietnam Pharmaceutical Gelatin Market Share (%), By Type, 2017-2031F
Figure 170. Vietnam Pharmaceutical Gelatin Market Share (%), By Source, 2017-2031F
Figure 171. Vietnam Pharmaceutical Gelatin Market Share (%), By Application, 2017-2031F
Figure 172. Vietnam Pharmaceutical Gelatin Market Share (%), By Function, 2017-2031F
Figure 173. Vietnam Pharmaceutical Gelatin Market Share (%), By End-User, 2017-2031F
Figure 174. South Korea Pharmaceutical Gelatin Market, By Value, In USD Billion, 2017-2031F
Figure 175. South Korea Pharmaceutical Gelatin Market, By Volume, In Billion Units, 2017-2031F
Figure 176. South Korea Pharmaceutical Gelatin Market Share (%), By Type, 2017-2031F
Figure 177. South Korea Pharmaceutical Gelatin Market Share (%), By Source, 2017-2031F
Figure 178. South Korea Pharmaceutical Gelatin Market Share (%), By Application, 2017-2031F
Figure 179. South Korea Pharmaceutical Gelatin Market Share (%), By Function, 2017-2031F
Figure 180. South Korea Pharmaceutical Gelatin Market Share (%), By End-User, 2017-2031F
Figure 181. Indonesia Pharmaceutical Gelatin Market, By Value, In USD Billion, 2017-2031F
Figure 182. Indonesia Pharmaceutical Gelatin Market, By Volume, In Billion Units, 2017-2031F
Figure 183. Indonesia Pharmaceutical Gelatin Market Share (%), By Type, 2017-2031F
Figure 184. Indonesia Pharmaceutical Gelatin Market Share (%), By Source, 2017-2031F
Figure 185. Indonesia Pharmaceutical Gelatin Market Share (%), By Application, 2017-2031F
Figure 186. Indonesia Pharmaceutical Gelatin Market Share (%), By Function, 2017-2031F
Figure 187. Indonesia Pharmaceutical Gelatin Market Share (%), By End-User, 2017-2031F
Figure 188. Philippines Pharmaceutical Gelatin Market, By Value, In USD Billion, 2017-2031F
Figure 189. Philippines Pharmaceutical Gelatin Market, By Volume, In Billion Units, 2017-2031F
Figure 190. Philippines Pharmaceutical Gelatin Market Share (%), By Type, 2017-2031F
Figure 191. Philippines Pharmaceutical Gelatin Market Share (%), By Source, 2017-2031F
Figure 192. Philippines Pharmaceutical Gelatin Market Share (%), By Application, 2017-2031F
Figure 193. Philippines Pharmaceutical Gelatin Market Share (%), By Function, 2017-2031F
Figure 194. Philippines Pharmaceutical Gelatin Market Share (%), By End-User, 2017-2031F
Figure 195. Middle East & Africa Pharmaceutical Gelatin Market, By Value, In USD Billion, 2017-2031F
Figure 196. Middle East & Africa Pharmaceutical Gelatin Market, By Volume, In Billion Units, 2017-2031F
Figure 197. Middle East & Africa Pharmaceutical Gelatin Market Share (%), By Type, 2017-2031F
Figure 198. Middle East & Africa Pharmaceutical Gelatin Market Share (%), By Source, 2017-2031F
Figure 199. Middle East & Africa Pharmaceutical Gelatin Market Share (%), By Application, 2017-2031F
Figure 200. Middle East & Africa Pharmaceutical Gelatin Market Share (%), By Function, 2017-2031F
Figure 201. Middle East & Africa Pharmaceutical Gelatin Market Share (%), By End-User, 2017-2031F
Figure 202. Middle East & Africa Pharmaceutical Gelatin Market Share (%), By Country, 2017-2031F
Figure 203. Saudi Arabia Pharmaceutical Gelatin Market, By Value, In USD Billion, 2017-2031F
Figure 204. Saudi Arabia Pharmaceutical Gelatin Market, By Volume, In Billion Units, 2017-2031F
Figure 205. Saudi Arabia Pharmaceutical Gelatin Market Share (%), By Type, 2017-2031F
Figure 206. Saudi Arabia Pharmaceutical Gelatin Market Share (%), By Source, 2017-2031F
Figure 207. Saudi Arabia Pharmaceutical Gelatin Market Share (%), By Application, 2017-2031F
Figure 208. Saudi Arabia Pharmaceutical Gelatin Market Share (%), By Function, 2017-2031F
Figure 209. Saudi Arabia Pharmaceutical Gelatin Market Share (%), By End-User, 2017-2031F
Figure 210. UAE Pharmaceutical Gelatin Market, By Value, In USD Billion, 2017-2031F
Figure 211. UAE Pharmaceutical Gelatin Market, By Volume, In Billion Units, 2017-2031F
Figure 212. UAE Pharmaceutical Gelatin Market Share (%), By Type, 2017-2031F
Figure 213. UAE Pharmaceutical Gelatin Market Share (%), By Source, 2017-2031F
Figure 214. UAE Pharmaceutical Gelatin Market Share (%), By Application, 2017-2031F
Figure 215. UAE Pharmaceutical Gelatin Market Share (%), By Function, 2017-2031F
Figure 216. UAE Pharmaceutical Gelatin Market Share (%), By End-User, 2017-2031F
Figure 217. South Africa Pharmaceutical Gelatin Market, By Value, In USD Billion, 2017-2031F
Figure 218. South Africa Pharmaceutical Gelatin Market, By Volume, In Billion Units, 2017-2031F
Figure 219. South Africa Pharmaceutical Gelatin Market Share (%), By Type, 2017-2031F
Figure 220. South Africa Pharmaceutical Gelatin Market Share (%), By Source, 2017-2031F
Figure 221. South Africa Pharmaceutical Gelatin Market Share (%), By Application, 2017-2031F
Figure 222. South Africa Pharmaceutical Gelatin Market Share (%), By Function, 2017-2031F
Figure 223. South Africa Pharmaceutical Gelatin Market Share (%), By End-User, 2017-2031F
Figure 224. By Type Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 225. By Source Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 226. By Application Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 227. By Function Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 228. By End-User Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 229. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023

Product Code: MX11553

Global pharmaceutical gelatin market is projected to witness a CAGR of 5.57% during the forecast period 2024-2031F, growing from USD 1.25 billion in 2023 to USD 1.92 billion in 2031F. Various factors shape the global pharmaceutical gelatin market. These include increased investments in research, technological advancements, high demand for porcine gelatin, rise in the popularity of gelatin capsules, growing demand in the European market, and companies increasingly seeking expansion opportunities.

One significant driver of the global pharmaceutical gelatin market is the increased investment in research and development initiatives. These initiatives aid in promoting innovation and technological advancements in the industry, which is required for growth and increased production. Gelatin is finding new uses in pharmaceuticals thanks to technological developments in drug delivery and gelatin-based therapeutics. The high demand for porcine gelatin is another major factor driving the growth of the global pharmaceutical gelatin market. The superior qualities of porcine gelatin make it extremely desirable for use in the pharmaceutical industry. The applications of porcine gelatin are increasing with advancements in technologies, which indicates its continued demand for the product in the future.

Advancements are improving the performance and adaptability of gelatin capsules in capsule technology, such as the creation of plant-based gelatin capsules, which is increasing their appeal to both producers and customers. Gelatin capsules are in high demand in the global pharmaceutical gelatin market because of their ability to protect the contents from air, light, microbial growth and contamination. The European market is an additional significant factor boosting the growth of the global pharmaceutical gelatin market. Pharmaceutical gelatin is becoming more and more essential due to the European Union's growing pharmaceutical market and strong pharmaceutical sector.

Finally, businesses seek variety and growth. The introduction of new gelatin brands and the growth of established ones into new areas are clear indications of this. These factors are anticipated to fuel the further growth and diversification of the global pharmaceutical gelatin market in the upcoming years.

For example, in May 2024, the Kerala State Industrial Development Corporation Ltd (KSIDC) and Nitta Gelatin Inc. Japan jointly launched an expansion project in Kerala valued at USD 7.18 million through Nitta Gelatin India Ltd (NGIL). This project is a portion of the USD 23.96 million investment that the Japanese MNC disclosed during the Kerala Chief Minister's most recent visit to Japan.

Research Initiatives Propel the Expansion of the Market

Due to the industry's growing research and development (R&D) activities, the global pharmaceutical gelatin market is expanding significantly on a large scale. Pharmaceutical corporations are heavily spending on research and development to create cutting-edge gelatin-based products like biodegradable capsules and sophisticated drug delivery systems. New gelatin brands and products have emerged as a result, such as X-Pure-GelDAT, a substitute for GelTYR-Gelatin Tyramine. Furthermore, it is anticipated that developments in gelatin production methods will boost productivity and affordability, propelling the expansion of the global pharmaceutical gelatin market.

For example, in January 2022, Darling Ingredients Inc. established a partnership with the Terasaki Institute for Biomedical Innovation (TIBI), a regenerative medicine research institute situated in California, through its Rousselot Health brand, which is the world leader in collagen-based solutions. Rousselot and TIBI will work together on the creation of gelatin-based treatments and their clinical application through this strategic alliance. Rousselot will provide TIBI with X-Pure modified gelatins, including X-Pure GelMA, in exchange for information on how gelatin behaves in the laboratory and throughout clinical trials.

Technological Advancements Spur Growth of the Market

Advancements in technologies such as nanotechnology, 3D printing, artificial intelligence, and machine learning are propelling the growth of the global pharmaceutical gelatin market. Pharmaceutical companies are making use of these technologies to produce novel gelatin-based goods that surpass the functionality and quality of conventional solutions. These technologies have made the development process of gelatin-based products more cost-effective and efficient. Gelatin is also being extensively used in other pharmaceutical sectors such as gene therapy, drug delivery systems, and tissue engineering. The application of gelatin in the pharmaceutical industry will continue to expand due to these technologies propelling the growth of the global pharmaceutical gelatin market.

For example, in December 2023, the health brand Rousselot from Darling Ingredients Inc. announced that it had received US Patent and Trademark Office (USPTO) Patent No. US11795489B2, securing its intellectual property rights for StabiCaps, a specialized gelatin that enhances the stability and formulation of soft gel capsules to improve drugs' release.

High Demand for Porcine Gelatin Drives Market Growth

Due to the unique characteristics of gel-forming ability and the biocompatible nature of porcine gelatin, it is commonly used in the pharmaceutical industry, bolstering the growth of the global pharmaceutical gelatin market. Porcine gelatin is known for its clarity and flexibility, which makes it excessively useful in the manufacturing of hard gelatin capsules, and it also has other applications in the pharmaceutical industry, such as soft capsules, absorbable hemostats, etc. It is also used as a stabilizer in vaccines to preserve its efficacy and safety throughout the transit and storage process. Porcine gelatin is a preferred choice for pharmaceutical manufacturers because of its ease of production, nutritious content, and reduced cost.

For instance, to save production costs and waste related to soft gel leakers, Gelita AG, a global leader in gelatin, introduced Easyseal gelatin in December 2023. The novel solution can be obtained in swine form that complies with food and drug administration (FDA) requirements, and a corresponding China Drug Masterfile is available to facilitate entry into the Chinese market.

Rise in the Popularity of Gelatin Capsules Fuels Market Growth

There is a huge demand for gelatin capsules because of their versatility and ease of use. A significant demand for dietary supplements and nutraceuticals has been seen in the last few years, boosting the growth of gelatin capsules in the global pharmaceutical gelatin market. There is an increased demand for gelatin capsules made from alternative sources because of the rise in inclination towards vegan lifestyles and plant-based food. Gelatin capsules are becoming more customizable and effective due to technological and formulation advances, which appeal to both manufacturers and consumers.

In September 2023, Strides Pharma Science Limited declared that the United States Food and Drug Administration (USFDA) has approved Icosapent Ethyl Capsules, 0.5 gram and 1 gram, through its step-down wholly owned subsidiary, Strides Pharma Global Pte, Singapore. The product enhances the selection of authorized soft gelatin capsules offered by Strides.

Europe Shows Dominance in the Pharmaceutical Gelatin Market

Europe's pharmaceutical gelatin market has observed significant growth over the past couple of years. Companies are focusing on producing new products through research and development to cater to the growing demand that has arisen because of the growing burden of chronic diseases and the rise in the geriatric population. The global pharmaceutical gelatin market participants focus on continuous clinical trials to improve the efficacy of the medications. The global pharmaceutical gelatin market is expanding due to pharmaceutical companies and concerned authorities meeting patient requirements, surpassing challenges such as the limitations of sustainability and ethical concerns.

For example, Caldic B.V. and Nitta Gelatin, Inc. announced that they had reached an agreement to form a strategic distribution relationship in Europe. Through this partnership, Caldic will be able to provide a greater selection of specialty gelatin products and a broad range of collagen products that perfectly match its current line of products for the Food, Nutrition, Pharma, and Personal Care markets. Starting on January 1, 2024, Caldic and Nitta Gelatin collaborated to create prospects in Benelux, France, Iberia, Italy, Germany, Austria, Switzerland, United Kingdom, and Ireland.

Future Market Scenario (2024-2031F)

The significant shift toward biodegradable gelatin capsules is considered a major factor driving the growth of the global pharmaceutical gelatin market in the future.

The global pharmaceutical gelatin market will witness a significant rise in the use of gelatin in the functional food industry.

Advanced technologies like nanotechnology and 3D printing are going to drive the global pharmaceutical gelatin market. These technologies are used to produce innovative gelatin products with enhanced properties.

An increased use of gelatin in cosmetics and personal care products is expected to significantly drive the growth of the global pharmaceutical gelatin market.

Key Players Landscape and Outlook

One of the main factors driving the expansion of the global pharmaceutical gelatin market is partnerships and collaborations. These partnerships guarantee that many viewpoints are considered to meet the needs of a diversified nature. Through successful collaborations, companies in the industry share their expertise in developing new and innovative solutions, increasing efficiency, and reducing costs. Companies also often collaborate to increase their expansion in the global pharmaceutical gelatin market and reach new customers.

For example, in March 2024, BIO INX B.V., a leading material developer for 3D bioprinting, announced a strategic relationship with Rousselot GmbH, a global leader in gelatin- and collagen-based solutions included in Darling Ingredients Inc. This partnership represents a significant advancement in the field of 3D bioprinting. As part of this partnership, Rousselot's X-Pure gelatin biomaterials, which are known for their dependability and quality, will be distributed by BIO INX for research and technical purposes.

1. Research Methodology

2. Project Scope and Definitions

3. Executive Summary

4. Global Pharmaceutical Gelatin Market Outlook, 2017-2031F

4.1. Market Size & Forecast
- 4.1.1. By Value
- 4.1.2. By Volume
4.2. By Type
- 4.2.1. Type A
- 4.2.2. Type B
4.3. By Source
- 4.3.1. Bovine
- 4.3.2. Porcine
- 4.3.3. Others
4.4. By Application
- 4.4.1. Hard Gelatin Capsules
- 4.4.2. Soft Gelatin Capsules
- 4.4.3. Others
4.5. By Function
- 4.5.1. Stabilizing
- 4.5.2. Thickening
- 4.5.3. Gelling
- 4.5.4. Others
4.6. By End-user
- 4.6.1. Pharmaceutical Companies
- 4.6.2. Biotechnology Companies
- 4.6.3. Academic and Research Institutions
4.7. By Region
- 4.7.1. North America
- 4.7.2. Europe
- 4.7.3. Asia-Pacific
- 4.7.4. South America
- 4.7.5. Middle East and Africa
4.8. By Company Market Share (%), 2023

5. Global Pharmaceutical Gelatin Market Outlook, By Region, 2017-2031F

5.1. North America*
- 5.1.1. Market Size & Forecast
  - 5.1.1.1. By Value
  - 5.1.1.2. By Volume
- 5.1.2. By Type
  - 5.1.2.1. Type A
  - 5.1.2.2. Type B
- 5.1.3. By Source
  - 5.1.3.1. Bovine
  - 5.1.3.2. Porcine
  - 5.1.3.3. Others
- 5.1.4. By Application
  - 5.1.4.1. Hard Gelatin Capsules
  - 5.1.4.2. Soft Gelatin Capsules
  - 5.1.4.3. Others
- 5.1.5. By Function
  - 5.1.5.1. Stabilizing
  - 5.1.5.2. Thickening
  - 5.1.5.3. Gelling
  - 5.1.5.4. Others
- 5.1.6. By End-user
  - 5.1.6.1. Pharmaceutical Companies
  - 5.1.6.2. Biotechnology Companies
  - 5.1.6.3. Academic and Research Institutions
- 5.1.7. United States*
  - 5.1.7.1. Market Size & Forecast
    - 5.1.7.1.1. By Value
    - 5.1.7.1.2. By Volume
  - 5.1.7.2. By Type
    - 5.1.7.2.1. Type A
    - 5.1.7.2.2. Type B
  - 5.1.7.3. By Source
    - 5.1.7.3.1. Bovine
    - 5.1.7.3.2. Porcine
    - 5.1.7.3.3. Others
  - 5.1.7.4. By Application
    - 5.1.7.4.1. Hard Gelatin Capsules
    - 5.1.7.4.2. Soft Gelatin Capsules
    - 5.1.7.4.3. Others
  - 5.1.7.5. By Function
    - 5.1.7.5.1. Stabilizing
    - 5.1.7.5.2. Thickening
    - 5.1.7.5.3. Gelling
    - 5.1.7.5.4. Others
  - 5.1.7.6. By End-user
    - 5.1.7.6.1. Pharmaceutical Companies
    - 5.1.7.6.2. Biotechnology Companies
    - 5.1.7.6.3. Academic and Research Institutions
- 5.1.8. Canada
- 5.1.9. Mexico

All segments will be provided for all regions and countries covered

5.2. Europe
- 5.2.1. Germany
- 5.2.2. France
- 5.2.3. Italy
- 5.2.4. United Kingdom
- 5.2.5. Russia
- 5.2.6. Netherlands
- 5.2.7. Spain
- 5.2.8. Turkey
- 5.2.9. Poland
5.3. Asia-Pacific
- 5.3.1. India
- 5.3.2. China
- 5.3.3. Japan
- 5.3.4. Australia
- 5.3.5. Vietnam
- 5.3.6. South Korea
- 5.3.7. Indonesia
- 5.3.8. Philippines
5.4. South America
- 5.4.1. Brazil
- 5.4.2. Argentina
5.5. Middle East and Africa
- 5.5.1. Saudi Arabia
- 5.5.2. UAE
- 5.5.3. South Africa

6. Market Mapping, 2023

6.1. By Type
6.2. By Source
6.3. By Application
6.4. By Function
6.5. By End-user
6.6. By Region

7. Macro Environment and Industry Structure

7.1. Demand Supply Analysis
7.2. Import Export Analysis
7.3. Value Chain Analysis
7.4. PESTEL Analysis
- 7.4.1. Political Factors
- 7.4.2. Economic System
- 7.4.3. Social Implications
- 7.4.4. Technological Advancements
- 7.4.5. Environmental Impacts
- 7.4.6. Legal Compliances and Regulatory Policies (Statutory Bodies Included)
7.5. Porter's Five Forces Analysis
- 7.5.1. Supplier Power
- 7.5.2. Buyer Power
- 7.5.3. Substitution Threat
- 7.5.4. Threat From New Entrant
- 7.5.5. Competitive Rivalry

8. Market Dynamics

8.1. Growth Drivers
8.2. Growth Inhibitors (Challenges and Restraints)

9. Regulatory Framework and Innovation

9.1. Patent Landscape
9.2. Regulatory Approvals
9.3. Innovations/Emerging Technologies

10. Key Players Landscape

10.1. Competition Matrix of Top Five Market Leaders
10.2. Market Revenue Analysis of Top Five Market Leaders (By Value, 2023)
10.3. Mergers and Acquisitions/Joint Ventures (If Applicable)
10.4. SWOT Analysis (For Five Market Players)
10.5. Patent Analysis (If Applicable)

11. Pricing Analysis

12. Case Studies

13. Key Players Outlook

13.1. Gelita AG
- 13.1.1. Company Details
- 13.1.2. Key Management Personnel
- 13.1.3. Products and Services
- 13.1.4. Financials (As Reported)
- 13.1.5. Key Market Focus and Geographical Presence
- 13.1.6. Recent Developments
13.2. Darling Ingredients Inc.
13.3. Nitta Gelatin, Inc.
13.4. Tessenderlo Group
13.5. Weishardt International
13.6. Lonza Group AG
13.7. Aspire Pharmaceuticals, Inc.
13.8. Junca Gelatines S.L
13.9. Gelco International
13.10. Trobas Gelatine BV

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

医薬品用ゼラチンの世界市場の評価：タイプ別、由来別、用途別、機能別、エンドユーザー別、地域別、機会、予測（2017年～2031年）

Pharmaceutical Gelatin Market Assessment, By Type, By Source, By Application, By Function, By End-user, By Region, Opportunities and Forecast, 2017-2031F

目次

第1章調査手法

第2章プロジェクトの範囲と定義

第3章エグゼクティブサマリー

第4章世界の医薬品用ゼラチン市場の見通し（2017年～2031年）

第5章世界の医薬品用ゼラチン市場の見通し：地域別（2017年～2031年）

第6章市場マッピング（2023年）

第7章マクロ環境と産業構造

第8章市場力学

第9章規制枠組みとイノベーション

第10章主要企業の情勢

第11章価格分析

第12章ケーススタディ

第13章主要企業の見通し

第14章戦略的推奨

第15章当社について、免責事項

List of Tables

List of Figures

Table of Contents

1. Research Methodology

2. Project Scope and Definitions

3. Executive Summary

4. Global Pharmaceutical Gelatin Market Outlook, 2017-2031F

5. Global Pharmaceutical Gelatin Market Outlook, By Region, 2017-2031F

6. Market Mapping, 2023

7. Macro Environment and Industry Structure

8. Market Dynamics

9. Regulatory Framework and Innovation

10. Key Players Landscape

11. Pricing Analysis

12. Case Studies

13. Key Players Outlook

14. Strategic Recommendations

15. About Us & Disclaimer

医薬品用ゼラチンの世界市場の評価：タイプ別、由来別、用途別、機能別、エンドユーザー別、地域別、機会、予測（2017年～2031年）

Pharmaceutical Gelatin Market Assessment, By Type, By Source, By Application, By Function, By End-user, By Region, Opportunities and Forecast, 2017-2031F

目次

第1章 調査手法

第2章 プロジェクトの範囲と定義

第3章 エグゼクティブサマリー

第4章 世界の医薬品用ゼラチン市場の見通し（2017年～2031年）

第5章 世界の医薬品用ゼラチン市場の見通し：地域別（2017年～2031年）

第6章 市場マッピング（2023年）

第7章 マクロ環境と産業構造

第8章 市場力学

第9章 規制枠組みとイノベーション

第10章 主要企業の情勢

第11章 価格分析

第12章 ケーススタディ

第13章 主要企業の見通し

第14章 戦略的推奨

第15章 当社について、免責事項

List of Tables

List of Figures

Table of Contents

1. Research Methodology

2. Project Scope and Definitions

3. Executive Summary

4. Global Pharmaceutical Gelatin Market Outlook, 2017-2031F

5. Global Pharmaceutical Gelatin Market Outlook, By Region, 2017-2031F

6. Market Mapping, 2023

7. Macro Environment and Industry Structure

8. Market Dynamics

9. Regulatory Framework and Innovation

10. Key Players Landscape

11. Pricing Analysis

12. Case Studies

13. Key Players Outlook

14. Strategic Recommendations

15. About Us & Disclaimer

第1章調査手法

第2章プロジェクトの範囲と定義

第3章エグゼクティブサマリー

第4章世界の医薬品用ゼラチン市場の見通し（2017年～2031年）

第5章世界の医薬品用ゼラチン市場の見通し：地域別（2017年～2031年）

第6章市場マッピング（2023年）

第7章マクロ環境と産業構造

第8章市場力学

第9章規制枠組みとイノベーション

第10章主要企業の情勢

第11章価格分析

第12章ケーススタディ

第13章主要企業の見通し

第14章戦略的推奨

第15章当社について、免責事項